IAM Insider Trading Activity and SEC Form 4 Filings
IAM insider trading summary
Over the past 12 months, insiders at Iambic Therapeutics, Inc. (IAM) reported 1 open-market purchase worth $11.5M by 1 insider and no sales on SEC Form 4. Net insider buying was $11.5M.
Latest IAM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Evan Lockwood Rachlin | Insider | Buy | $11.5M (718,750 @ $16.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.